Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study (Q44996394)

8 December 2017

Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study (English)

1 reference

8 December 2017

Deborah Layton

1

1 reference

PubMed ID

15278327

8 December 2017

Lynda V Wilton

series ordinal

2

1 reference

PubMed ID

15278327

8 December 2017

Saad A W Shakir

series ordinal

3

1 reference

8 December 2017

1 September 2004

1 reference

European Journal of Clinical Pharmacology

8 December 2017

1 reference

8 December 2017

60

1 reference

8 December 2017

489-501

1 reference

8 December 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-004-0788-2

8 December 2017

0 references

cites work

General practice postal surveys: a questionnaire too far?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-004-0788-2

Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-004-0788-2

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

21 January 2018

1 reference

12 December 2020

Principles of signal detection in pharmacovigilance

1 reference

12 December 2020

Prescription-event monitoring--recent progress and future horizons

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.

1 reference

12 December 2020

Identification of sulfonamide-like adverse drug reactions to celecoxib in the World Health Organization database

1 reference

12 December 2020

Celecoxib clinical profile

1 reference

12 December 2020

Celecoxib-induced acute pancreatitis and hepatitis: a case report

1 reference

12 December 2020

Clinical response to nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data

1 reference

12 December 2020

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib

1 reference

12 December 2020

Fatal allergic vasculitis associated with celecoxib

1 reference

12 December 2020

Celecoxib-induced erythema multiforme with glyburide cross-reactivity

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Are selective COX 2 inhibitors superior to traditional NSAIDs? Pharmacia's response to editorial

1 reference

12 December 2020

Cyclo-oxygenase isoenzymes: physiological and pharmacological role

1 reference

12 December 2020

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial

1 reference

12 December 2020

The role of non-steroidal anti-inflammatory drugs in acute liver injury

1 reference

12 December 2020

Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases

1 reference

12 December 2020

Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data

1 reference

12 December 2020

Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs).

1 reference

12 December 2020

The effect of cash and other financial inducements on the response rate of general practitioners in a national postal study

1 reference

12 December 2020

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

1 reference

12 December 2020

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

1 reference

12 December 2020

Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease.

1 reference

12 December 2020

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

12 December 2020

Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice

1 reference

12 December 2020

Migratory pulmonary infiltrates in a patient with rheumatoid arthritis

1 reference

12 December 2020

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

1 reference

12 December 2020

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

1 reference

12 December 2020

Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Comparative toxicity of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Urticaria and angioedema from cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Visual disturbance associated with celecoxib

1 reference

12 December 2020

COX-2 inhibition and thrombotic tendency: a need for surveillance

1 reference

12 December 2020

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

1 reference

12 December 2020

Celecoxib-induced nonoliguric acute renal failure

1 reference

12 December 2020

Prescription-event monitoring and reporting of adverse drug reactions

1 reference

12 December 2020

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

12 December 2020

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

1 reference

12 December 2020

The diagnosis of adverse medical events associated with drug treatment

1 reference

12 December 2020

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

12 December 2020

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

1 reference

12 December 2020

Effect of mailed reminders on the response rate in surveys among patients in general practice.

1 reference

12 December 2020

Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology

1 reference

12 December 2020

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

1 reference

12 December 2020

The CIOMS guidelines for biomedical research involving human subjects.

1 reference

12 December 2020

Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group

1 reference

12 December 2020

Basic biology and clinical application of specific cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Celecoxib, rofecoxib, and acute temporary visual impairment

1 reference

12 December 2020

Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor

1 reference

12 December 2020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

Case of cholestatic hepatitis with celecoxib did not fulfil international criteria

1 reference

12 December 2020

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

12 December 2020

Results of a postal survey of the reasons for non-response by doctors in a Prescription Event Monitoring study of drug safety

1 reference

12 December 2020

The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study

1 reference

12 December 2020

Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor

1 reference

12 December 2020

Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events

1 reference

12 December 2020

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

1 reference

12 December 2020

Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease

1 reference

12 December 2020

Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee

1 reference

12 December 2020

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial

1 reference

12 December 2020

Surveying general practitioners: does a low response rate matter?

1 reference

12 December 2020

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

12 December 2020

Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study

1 reference

12 December 2020

Anaphylaxis to celecoxib

1 reference

12 December 2020

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

1 reference

12 December 2020

Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy

1 reference

12 December 2020

Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis

1 reference

12 December 2020

10.1007/S00228-004-0788-2

Identifiers

DOI

1 reference

8 December 2017

1 reference

PubMed ID

15278327